Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Recent rumours that Biogen was about to acquired by Samsung proved unfounded, but it turns out a deal has been in preparation. The South Korean firm just agreed to buy Biogen out of their ...

Biogen BIIB reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.44, which beat the Zacks Consensus Estimate ...

In Honeywell International Inc. v. 3G Licensing, S.A., Appeal No. 23-1354, the Federal Circuit held that under the obviousness standard of 35 U.S.C.

Samsung Electronics Chairman Lee Jae-yong was acquitted in an appellate trial on Feb. 3, clearing him of stock manipulation ...

The Italian Competition Authority (Autorità Garante della Concorrenza e del Mercato, or AGCM) said its probe also covers subsidiaries of Samsung Bioepis and Biogen and Roche’s Genentech unit ...

Addressing a preliminary injunction in patent litigation related to the Biologics Price Competition and Innovation Act (BPCIA), the US Court ...

Biogen's 2025 forecasts hit by declining sales ... Incyte forecasts downbeat annual sales of skin disease drug, shares fall Samsung Electronics Chairman Jay Y. Lee was found not guilty of ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Pharmaceutical giant AbbVie has inked another ...

Sadda reported financial relationships with AbbVie/Allergan, Alexion, Apellis, Astellas/Iveric, Bayer, Biogen, Boehringer ... Roche/Genentech, Samsung Bioepis, Carl Zeiss Meditec AG, iCare ...